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Introduction
The chronic proximal plantar fasciitis is associated with
a painful, often intolerable and invariably incapacitating
symptoms in the inferior surface of the heel, that char-
acteristically worse on ﬁrst arising in the morning or
after a period of rest and decreases as they start to walk.
Pathology studies done on surgically removed speci-
mens demonstrated microtears of fascia, collagen
necrosis, angioﬁbroblastic hyperplasia and chondroid
metaplasia [8]. On average, 50% of the patients with heel
pain have an inferior calcaneal bone spur adjacent to the
plantar fascial enthesis [2, 7, 15, 17]. This spur may be a
reaction to altered fascial mechanics, inﬂammation or
mechanical stimulation of the plantar soft tissue [3, 15].
The runners at recreational jogging or at competitive
level may be susceptible to suﬀer this problem [4]. A
wide range of treatments have been suggested, consisting
of decreasing activity, heel cord stretching, night splints,
anti-inﬂammatory drugs, heel cups, pads and orthotics
[4], which in most cases can resolve the problem,
although the symptoms can persist for 10–12 months.
More recently extracorporeal shock wave therapy
(ESWT) has been used in the treatment of a number of
musculoskeletal condition, including plantar fasciitis.
The rational of this treatment is the stimulation of soft
tissue healing, reduction of calciﬁcation, inhibition of
pain receptors or denervation to achieve pain relief
[6, 10, 18]. The eﬃcacy of this treatment seems to be
dependent on doses and regimes [19].
The aim of this paper is to assess the beneﬁt to treat
plantar fasciitis with low-dose energy ESWT and the
eﬃcacy of such treatment to abate the painful symptoms
allowing a rapid return to the running activity.
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Abstract The aim of this paper is to
assess the beneﬁt to treat plantar
fasciitis with low-dose energy extra-
corporeal shock wave therapy
(ESWT) and the eﬃcacy of such
treatment to abate the painful
symptoms allowing a rapid return to
the running activity. Our study in-
cluded 54 running athletes treated
for plantar fasciitis associated with a
heel spur who received four sessions
(once weekly) of low-dose ESWT,
and followed prospectively on aver-
age 45 days, 6 and 24 months after
their last session. The clinical results
were excellent in 59% of cases, good
in 12%, satisfactory in 21% and
distinctly unsatisfactory in 8%. No
patient was observed a signiﬁcant
modiﬁcation of the heel spur at the
follow-up X-ray. The ultrasound
examination at 24 months showed a
disappearance of the inﬂammation
signs in 61% of cases. A strong
correlation between ultrasound
improvement and clinical results
were found. Low-energy ESWT
seems to be a good mean to treat
plantar fasciitis in runners with a
71% of good or excellent results and
a persistent improvement lasting
24 months. A randomized multicen-
tric study seems to be necessary to
deﬁne the type of energy that should
be used in the future to treat plantar
fasciitis, in particular in the athletic
patients, to allow a faster return to
sports activities.
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Materials and methods
Our trial included 54 running athletes treated for plantar
fasciitis between January 2000 and January 2002. There
were 20 competitive level runners and 34 recreational
joggers, with a mean age of 35.2 years (range 30–42).
The symptoms were unilateral in all the cases. Our
inclusion criteria were the following: the presence of a
chronic pain (at least 6 months of duration) at the
proximal insertion of the plantar fascia in the inferior
heel, which failed to respond to a trial of conservative
treatment including medical, physical therapy, local
injection and orthotic devices. The presence of heel spur
on the lateral X-ray view of foot before start of the
treatment was our second criteria of inclusion. An
ultrasound evaluation using an ESAOTE AU 5 Genova
device with linear 50 MHz probe was performed in the
region of maximal tenderness by a physician participant
in the study. The treatment protocol consisted in a
course of four sessions (once weekly), with 2,000 pulses
being delivered at each session at an average of 0.04 mJ
mm2, using a electromagnetic lithotripter (MINILITH
SL1 by STORZ MEDICAL) with cylindrical coil, par-
abolic focus and ultrasound in-line scanning.
No local anesthetic was used during session of
treatment. We aimed the device directly at the medial
tubercle of the calcaneus, at the proximal insertion of the
plantar fascia or the calcaneal spur, around the prede-
termined point of medial tenderness.
The patients were invited to come back at an
average of 45 days, 6 and 24 months since their last
ESWT session. At follow-up we have evaluated the
pain levels using the VAS scale (where ten represented
unbearable pain and zero absence of pain). The values
taken were the average score at rest, during the ﬁrst
morning steps and after running or jogging. At each
follow-up visit, the dolorimeter was applied to the
baseline (pretreatment) and the patient was asked to
rate the VAS. At the same intervals of time a lateral
weight-bearing X-ray of the foot and ultrasound
evaluation using an ESAOTE AU 5 Genova device
with linear 50 MHz probe was performed.
We deﬁned the clinical results as follows: excellent,
patients who reported a subjective decrease in pain
ranging from 100 to 70%; very good, a decrease from 70
to 30% (VAS); satisfactory a decrease of less than 30%
(VAS); and unsatisfactory results in which the clinical
picture was unchanged or worse.
We checked our assumption using Student’s t test for
dependent samples, and we used Pearson’s correlation
coeﬃcient to measure the linear association between two
characters.
Results
Before start of the treatment, the ultrasound evaluation
showed signs of inﬂammation such as, oedema or bur-
sitis around the proximal insertion of the plantar fascia,
in all cases.
The mean VAS before treatment was 7.64 (SD 1.48).
At the 6-week follow-up, the mean VAS was 3.55 (SD
3.06), at 6 months the value was 3.05 (SD 2.56) and at
24 months 2.8 (SD 3.30), Fig. 1.
Based on the aforementioned parameters, we had
excellent results in 59% of cases (32 patients), very good
results in 12% (seven patients), satisfactory results in
21% (11 patients) and distinctly unsatisfactory results in
8% (four patients), Fig. 2.
Fifty patients were able, although a diﬀerent level of
satisfactory, to resume them athletic activities as high as
before this treatment at a mean time of 34 days (range
28–45 days) after starting the treatment.
The remaining four patients were not able to resume
athletic activities because of persistence of symptoms.
Three of these patients underwent surgical management
consisting in a plantar fascia release and removal of the
inﬂamed necrotic fascia with a satisfactory result; the
last patient refused any surgical treatment; it was a
recreational jogger at a low level and continued occa-
sionally his jogging using heel cup and taking some-
times, anti-inﬂammatory no-steroidal drugs.
In no case, fragmentation or disappearance of the
heel spur was observed at the X-ray performed during
the follow-up time.
The ultrasound evaluation at 24 months showed that
21 patients (39%) still showed evidence of inﬂammation,
but 33 patients (61%) showed a complete disappearance
of the inﬂammatory signs. In the group in which we had
excellent and very good results (39 patients 71%),
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Fig. 1 The graph shows the mean value of pain (VAS) at the time 0
(pretreatment time) and at the follow-up time
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(28 patients 71%) showed ultrasound evidence of
improvement with no sign of inﬂammation, while in 11
patients (28%) clear evidence of inﬂammation still per-
sisted. In the group in which we had discrete and poor
results (15 patients, 29%), only in six patients (40%) we
do not found evidence of inﬂammation, while in nine
patients (60%) the inﬂammation persisted. We observed
a strong correlation between improvements evidenced
by ultrasound at the 24-month follow-up and improve-
ments in reported pain on the VAS scale (r=0.30
statistically signiﬁcant for P=0.001), Fig. 3.
Discussion
The plantar fascia plays a dominant role, during weight-
bearing activities, contributing a larger proportion of
maintenance of the arch than the spring ligament or
plantar ligaments [12]. The calcaneum attachment site is
subjected to tensile stress with weight bearing and
locomotion. The runners, at whatever level can be pre-
dispose to develop plantar fasciitis, due to overuse,
training errors or footwear. Due to the repetitive nature
of walking activities, plantar fasciitis can become a
chronic problem, characterized by a chronic inﬂamma-
tion and microtears in the plantar fascia, as evidenced in
the three cases who were operated on, in our series.
Inﬂammation of the plantar fascia, and the resulting
bursitis, seems to be responsible of heel pain, while the
heel spur do not have nerve endings of its own and is
thus asymptomatic. The heel spur is merely an associ-
ated ﬁnding that indicates the presence of long-standing
bursitis and plantar fasciitis, but in some cases, it can be
large enough to be causing mechanical pain or com-
pressing the ﬁrst branch of the lateral plantar nerve [4].
In our series using ultrasound, the presence of
inﬂammatory signs was noted at the pretreatment time
in all the cases, and the reduction of these signs at fol-
low-up was well correlated with good results.
The presence of heel spur was a criteria of inclusion in
our study, so it was impossible to deﬁne the correlation
between this ﬁnding and plantar fasciitis. In the litera-
ture, an incidence between 50% [2, 15] and 65% [13] is
reported. On the other hand, not all patients with heel
spurs have a conﬁrmed diagnosis of chronic proximal
plantar fasciitis [2]. The reason to insert the presence of
heel spur into the inclusion criteria was to have a group
as homogeneous as possible, and to verify at the end of
treatment the fate of heel spur and an eventually cor-
relation with the results observed. Our results are similar
to that reported by Lee et al. [13], which observed no
modiﬁcation of heel spur at the last of treatment, con-
ﬁrming that the presence of the heel spur do not have
any correlation with the ﬁnal outcome.
On the other hand, we have found a strong correla-
tion between the disappearance of inﬂammatory signs at
the ultrasound examination and the ﬁnal outcome. This
ﬁnding seems to conﬁrm the anti-inﬂammatory eﬀect of
ESWT [6], but do not help to understand the causes of
8% of unsatisfactory results found in our series. Some
authors, who using low-energy ESWT [10, 11, 14, 20,
21], has found that the pressure of bone marrow oedema
within the calcaneus, demonstrated by bone scan and
overall by MRI was highly predictive for a satisfactory
ﬁnal outcome. Nevertheless, the area of the fascial
attachment at the medial calcaneal tubercle may show
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Fig. 2 The results obtained with the treatment of low-energy
ESWT
Fig. 3 a An ultrasound examination performed before starting
ESWT treatment showing evidence of acute bursitis around the
proximal insertion of the plantar fascia. b The same investigation
performed in the same subject, which reported an excellent result at
24-month follow-up, shows the absence of signs of inﬂammation
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an increased uptake at bone scan indicative of a focal
osseous stress reaction [9, 21]. We do not have any
experience with these types of examens to study this
injury, but at the light of literature.
We can speculate that overall in competitive athletes
suﬀering of plantar fasciitis may be necessary to use
MRI, so a rationale treatment can be planned.
In general, our study, although performed on a par-
ticular category of subjects, shows results similar to the
ones of previous studies using low ESWT in treatment of
plantar fasciitis [1, 5, 14, 16, 18]. Speed et al. [19] in a
double-blind randomized controlled trial has found no
treatment eﬀect of low-dose ESWT to treat plantar
fasciitis, but the treatment was applied monthly rather
than weekly interval as in recommended protocol.
Recently, the use of high energy ESWT has received
FDA approval speciﬁcally for the treatment of plantar
fasciitis, following an evaluation period involving seven
research institutes and including double-blind placebo-
controlled trials, with a 76% success rate after just one
treatment [16]. Lee et al. [13] reported an 80% of success
using one and sometimes two sessions of treatment. The
advantage of high energy ESWT is surely the short time
of treatment, in fact, as aforementioned, sometimes a
single session can be suﬃcient and curative allowing a
faster resumption of sports activities. The problem with
this type of treatment is the pain during the session of
treatment requiring a conscious sedation or ankle block
anesthesia [13].
In conclusion, low-energy ESWT seems to be a good
mean to treat plantar fasciitis in runners, with a 71% of
good or excellent results and a persistent improvement
lasting 24 months. The ultrasound improvements of
inﬂammatory signs match clinical ﬁndings in 61% of
cases at subsequent follow-up. The routine use of MRI
at the time of diagnosis can be suggested to probably
better deﬁne the patients who will beneﬁciate of ESWT
treatment, allowing overall to the athletes a less time
consuming. A randomized multicentric study seems to
be necessary to deﬁne the type of energy that should be
used in the future to treat plantar fasciitis, in particular
in the athletic patients, to allow a faster return to sports
activities. It will be interesting too to compare this
technique with the others as surgery, steroid inﬁltration
or radiotherapy. Steroid inﬁltration is still unsatisfac-
tory. Radiotherapy is limited by the risk of the radio-
inductive sarcoma and surgery can be used by echec of
ESWT treatment.
References
1. Abt T, Hopfermuller W, Mellerowicz H
(2002) Shock wave therapy for re-
calcitrant plantar fasciitis with heel
spur: a prospective a randomized pla-
cebo-controlled double-blind study.
Orthop Ihre Grenzgeb 140(5):548–554
2. Amis J, Jennings L, Graham CE (1998)
Painful heel syndrome: radiographic
and treatment assessment. Foot Ankle
9:91–99
3. Barret SL, Day SV, Pignetti T, Egly BR
(1995) Endoscopic heel anatomy: anal-
ysis of 200 fresh frozen specimens.
J Foot Ankle Surg 34:51–56
4. Baxter DE, Yingas C (1995) The foot in
running. J Am Acad Orthop Surg
3:136–145
5. Buch M, Knor U, Fleming L, et al
(2002) Extracorporeal shockwave ther-
apy in symptomatic heel spurs—an
overview. Orthopade 31(7):637–644
6. Delius M (1994) Medical applications
and bioeﬀects of extracorporeal shock
waves. Shock Waves 4:55–72
7. Furey JP (1975) Plantar fasciitis: the
painful heel syndrome. J Bone Joint
Surg 57A:672–674
8. Gill LH (1997) Plantar fasciitis diagno-
sis and conservative management. J Am
Acad Orthop Surg 5:109–115
9. Graham CE (1983) Painful heel syn-
drome: rationale of diagnosis and
treatment. Foot Ankle 3:261–267
10. Grasel RP, Schweitzer ME, Kovalovich
AM, et al (1999) MR imaging of plantar
fasciitis: edema, tears, and occult mar-
row abnormalities correlated with out-
come. Am J Roentgenol 173:699–701
11. Ham PS, Strayer S (2002) Shock wave
therapy ineﬀective for plantar fasciitis.
J Fam Pract 51(12):1017–1022
12. Huang CK, Kitaoka HB, An KN et al
(1993) Biomechanical evaluation of
longitudinal arch stability. Foot Ankle
14:353–357
13. Lee GP, Ogden JA, G Lee Cross (2003)
Eﬀect of extracorporeal shock waves on
calcaneal bone spurs. Foot Ankle Int
23:301–308
14. Maier M, Steinborn M, Schmitz C, et al
(2000) Extracorporeal shock wave
application for chronic plantar fasciitis
associated with heel spurs: prediction of
outcome by magnetic resonance imag-
ing. J Rheumatol 27:2455–2462
15. McCarthy JJ, Goreecky GE (1979)
Anatomical basis of inferior calcaneal
lesions: a cryomicrotomy study. J Am
Pediatr Assoc 69:527–536
16. Ogden JA, Alvarez R, Levitt R, Cross
GL, Marlow M (2001) Shockwave
therapy for chronic proximal plantar
fasciitis. Clin Orthop 387:47–59
17. Onwuanyo ON (2000) Calcaneal spurs
and plantar heel pad pain. Foot 10:182–
185
18. Rompe JD, Hopf C, Nafe B, Burger R
(1996) Low-energy extracorporeal
shock wave therapy for painful heel: a
prospective controlled single-bind
study. J Orthop Trauma Surg 115:75–79
19. Speed CA, Nichols D, Wies J, et al
(2003) Extracoropreal shock wave
therapy for plantar fasciitis. A double-
blind randomised controlled trial.
J Orthop Res 21:937–940
20. Steinborn M, Heuck A, Maier M, Sch-
narkowski P, Scheidler J, Reiser M
(1999) MRI of plantar fasciitis. Rogo
Fortschr Geb Roentgenstr 170:41–46
21. Tudor GR, Finlay D, Allen MJ, Belton
J (1997) The role of bone scintigraphy
and plain radiography in intractable
plantar fasciitis. Nucl Med Commen
18:853–856
1032
